Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-07-09 Sale | 2025-07-11 5:27 pm | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 27,000 | $7.502 | $202,554 | 1,093,313 (Indirect) | View |
| 2025-06-27 Sale | 2025-07-01 8:33 pm | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 125,000 | $6.9331 | $866,633 | 1,100,248 (Indirect) | View |
| 2024-10-15 Purchase | 2024-10-15 5:56 pm | Camp4 Therapeutics Corp | CAMP | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH 10% Owner | 909,090 | $11 | $9,999,990 | 2,625,145 (Indirect) | View |
| 2024-09-11 Sale | 2024-09-13 6:54 pm | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 266,337 | $6.5719 | $1,750,352 | 66,277 (Indirect) | View |
| 2024-07-22 Purchase | 2024-07-24 4:15 pm | Artiva Biotherapeutics Inc. | ARTV | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 833,333 | $12 | $9,999,996 | 1,643,741 (Indirect) | View |
| 2024-03-13 Purchase | 2024-03-15 4:15 pm | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 450,000 | $10 | $4,500,000 | 10,179,505 (Indirect) | View |
| 2024-02-14 Sale | 2024-02-16 4:15 pm | Enliven Therapeutics Inc. | ELVN | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 825,000 | $14.9 | $12,292,500 | 635,341 (Indirect) | View |
| 2024-01-31 Purchase | 2024-02-02 4:32 pm | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 5,206,074 | $2.31 | $12,026,031 | 9,729,505 (Indirect) | View |
| 2024-01-31 Sale | 2024-02-02 4:29 pm | Enliven Therapeutics Inc. | ELVN | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 500,000 | $15 | $7,500,000 | 771,983 (Indirect) | View |
| 2023-09-26 Sale | 2023-09-28 4:27 pm | Enliven Therapeutics Inc. | ELVN | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 197,500 | $15 | $2,962,500 | 854,796 (Indirect) | View |
| 2023-08-24 Sale | 2023-08-28 4:20 pm | Enliven Therapeutics Inc. | ELVN | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 440,000 | $16 | $7,040,000 | 887,507 (Indirect) | View |
| 2023-03-07 Sale | 2023-03-09 4:39 pm | Rallybio Corp | RLYB | PARMAR KUSH Director | 100,000 | $8.2 | $820,000 | 3,630,724 (Indirect) | View |
| 2022-08-15 Purchase | 2022-08-17 8:01 pm | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. 10% Owner | 600,000 | $30 | $18,000,000 | 983,656 (Indirect) | View |
| 2022-06-03 Sale | 2022-06-07 5:03 pm | Rallybio Corp | RLYB | PARMAR KUSH Director 10% Owner | 150,000 | $12.5 | $1,875,000 | 1,251,755 (Indirect) | View |
| 2022-05-23 Sale | 2022-05-25 6:34 pm | Rallybio Corp | RLYB | PARMAR KUSH Director 10% Owner | 100,000 | $13 | $1,300,000 | 1,302,084 (Indirect) | View |
| 2022-02-08 Sale | 2022-02-10 6:22 pm | Rallybio Corp | RLYB | PARMAR KUSH Director | 210,000 | $13.05 | $2,740,500 | 1,335,637 (Indirect) | View |
| 2022-01-11 Purchase | 2022-01-13 4:45 pm | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 10% Owner | 470,000 | $16 | $7,520,000 | 496,323 (Indirect) | View |
| 2021-11-16 Sale | 2021-11-18 8:10 pm | Vor Biopharma Inc. | VOR | PARMAR KUSH Director 10% Owner | 330,706 | $15.3 | $5,059,802 | 1,766,634 (Indirect) | View |
| 2021-11-02 Purchase | 2021-11-05 08:49 am | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 250,000 | $20 | $5,000,000 | 1,132,357 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-11 Option Award | 2025-06-12 08:10 am | N/A 2035-06-11 | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 19,000 | $0 | 19,000 (Direct) | View |
| 2024-10-15 Conversion | 2024-10-15 5:56 pm | N/A N/A | Camp4 Therapeutics Corp | CAMP | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH 10% Owner | 24,661,577 | $0 | 2,625,145 (Indirect) | View |
Ownership | 2024-10-10 9:15 pm | N/A N/A | Camp4 Therapeutics Corp | CAMP | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH 10% Owner | 0 | $0 | 2,018,825 (Indirect) | View |
| 2024-07-22 Conversion | 2024-07-24 4:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 2,116,568 | $0 | 1,643,741 (Indirect) | View |
| 2024-07-22 Other | 2024-07-24 4:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 461,687 | $10.2 | 1,643,741 (Indirect) | View |
Ownership | 2024-07-18 8:06 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | 5AM Partners VI LLC 5AM Ventures VI L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 0 | $0 | 1,058,284 (Indirect) | View |
| 2024-06-13 Option Award | 2024-06-14 4:39 pm | N/A 2034-06-13 | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 16,000 | $0 | 16,000 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-17 5:05 pm | N/A 2034-05-15 | Rallybio Corp | RLYB | PARMAR KUSH Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 5:58 pm | N/A 2034-01-02 | Rallybio Corp | RLYB | PARMAR KUSH Director | 27,118 | $1.77 | 27,118 (Direct) | View |
Ownership | 2023-08-28 4:18 pm | N/A N/A | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 0 | $0 | 1,557,205,277 (Indirect) | View |
| 2023-06-08 Option Award | 2023-06-12 4:06 pm | N/A 2033-06-08 | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 5:26 pm | N/A 2033-05-17 | Rallybio Corp | RLYB | PARMAR KUSH Director | 15,490 | $0 | 15,490 (Direct) | View |
Ownership | 2023-03-06 5:18 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. PARMAR KUSH 10% Owner | 0 | $0 | 5,798,475 (Indirect) | View |
| 2023-02-24 Equity Swap | 2023-02-28 4:29 pm | N/A N/A | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. 5AM Opportunities I (GP) LLC 10% Owner | 4,937,646 | $0 | 0 (Indirect) | View |
| 2023-01-03 Option Award | 2023-01-05 6:29 pm | N/A 2033-01-03 | Rallybio Corp | RLYB | PARMAR KUSH Director | 10,344 | $0 | 10,344 (Direct) | View |
| 2022-11-30 Equity Swap | 2022-12-02 4:49 pm | N/A N/A | Akouos Inc. | AKUS | PARMAR KUSH Director 10% Owner | 4,135,786 | $0 | 0 (Indirect) | View |
| 2022-06-23 Option Award | 2022-06-27 5:02 pm | N/A 2032-06-22 | Akouos Inc. | AKUS | PARMAR KUSH Director 10% Owner | 16,000 | $0 | 16,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:05 pm | N/A 2032-06-15 | Homology Medicines Inc. | FIXX | PARMAR KUSH Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 5:09 pm | N/A 2032-06-13 | Vor Biopharma Inc. | VOR | PARMAR KUSH Director 10% Owner | 16,911 | $0 | 16,911 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 4:01 pm | N/A 2032-06-02 | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 11,918 | $0 | 11,918 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 8:08 pm | N/A 2032-05-24 | Rallybio Corp | RLYB | PARMAR KUSH Director | 13,440 | $0 | 13,440 (Direct) | View |
| 2022-01-11 Conversion | 2022-01-13 4:45 pm | N/A N/A | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 10% Owner | 17,017,645 | $0 | 496,323 (Indirect) | View |
Ownership | 2022-01-06 9:02 pm | N/A N/A | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 10% Owner | 0 | $0 | 3,867,646 (Indirect) | View |
| 2022-01-03 Option Award | 2022-01-05 8:38 pm | N/A 2032-01-03 | Rallybio Corp | RLYB | PARMAR KUSH Director | 5,772 | $0 | 5,772 (Direct) | View |
| 2021-11-02 Conversion | 2021-11-05 08:49 am | N/A N/A | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 3,827,224 | $0 | 1,132,357 (Indirect) | View |
Ownership(A) | 2021-11-05 08:48 am | N/A N/A | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 0 | $0 | 2,371,739 (Indirect) | View |